المؤلفون: Paul E., Quach H., Bazargan A., Ku M., Tey A., Shortt J., Opat S., Tam C., Filshie R., Gregory G.P., Gilberston M., Tatarczuch M.

مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443
Leukemia and Lymphoma
Click here for full text options
LibKey Link

المؤلفون: Fleming S., Loh J.B.E., Walker P., Avery S., Patil S., Spencer A., Wei A.

مصطلحات الفهرس: female, gene mutation, graft recipient, haploidentical transplantation, human, induction chemotherapy, letter, leukemia relapse, leukemia remission, male, minimal residual disease, monosomy 7, multiple cycle treatment, myeloblast, myelodysplastic syndrome, pancytopenia/dt [Drug Therapy], priority journal, real time reverse transcription polymerase chain reaction, renal replacement therapy-dependent renal disease, sibling donor, transplantation conditioning, unrelated donor, cyclosporine/dt [Drug Therapy], cyclosporine/tm [Unexpected Outcome of Drug Treatment], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], DNA methyltransferase 3A/ec [Endogenous Compound], etoposide/dt [Drug Therapy], fludarabine, idarubicin/dt [Drug Therapy], idarubicin/pv [Special Situation for Pharmacovigilance], melphalan, nucleophosmin/ec [Endogenous Compound], thiotepa, thymocyte antibody/dt [Drug Therapy], venetoclax/dt [Drug Therapy], consolidation chemotherapy, CD135 antigen/ec [Endogenous Compound], CD33 antigen/ec [Endogenous Compound], cyclophosphamide, acute myeloid leukemia/dt [Drug Therapy], adult, aged, allogeneic stem cell transplantation, aplastic anemia/dt [Drug Therapy], bone marrow biopsy, cancer chemotherapy, cancer patient, case report, chimera, clinical article, continuous infusion, DNA methylation, dysplasia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27242
Leukemia and Lymphoma
Click here for full text options
LibKey Link

المؤلفون: Paul E., Quach H., Bazargan A., Ku M., Tey A., Shortt J., Opat S., Tam C., Filshie R., Gregory G.P., Gilberston M., Tatarczuch M.

مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443
Leukemia and Lymphoma
LibKey Link

المؤلفون: Fleming S., Loh J.B.E., Walker P., Avery S., Patil S., Spencer A., Wei A.

مصطلحات الفهرس: female, gene mutation, graft recipient, haploidentical transplantation, human, induction chemotherapy, letter, leukemia relapse, leukemia remission, male, minimal residual disease, monosomy 7, multiple cycle treatment, myeloblast, myelodysplastic syndrome, pancytopenia/dt [Drug Therapy], priority journal, real time reverse transcription polymerase chain reaction, renal replacement therapy-dependent renal disease, sibling donor, transplantation conditioning, unrelated donor, cyclosporine/dt [Drug Therapy], cyclosporine/tm [Unexpected Outcome of Drug Treatment], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], DNA methyltransferase 3A/ec [Endogenous Compound], etoposide/dt [Drug Therapy], fludarabine, idarubicin/dt [Drug Therapy], idarubicin/pv [Special Situation for Pharmacovigilance], melphalan, nucleophosmin/ec [Endogenous Compound], thiotepa, thymocyte antibody/dt [Drug Therapy], venetoclax/dt [Drug Therapy], consolidation chemotherapy, CD135 antigen/ec [Endogenous Compound], CD33 antigen/ec [Endogenous Compound], cyclophosphamide, acute myeloid leukemia/dt [Drug Therapy], adult, aged, allogeneic stem cell transplantation, aplastic anemia/dt [Drug Therapy], bone marrow biopsy, cancer chemotherapy, cancer patient, case report, chimera, clinical article, continuous infusion, DNA methylation, dysplasia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27242
Leukemia and Lymphoma
LibKey Link

المؤلفون: Taubenheim N., Shortt J., Opat S., Wong J., Wall M., Corboy G.P., Gregory G.P.

مصطلحات الفهرس: febrile neutropenia/si [Side Effect], female, flow cytometry, fluorescence in situ hybridization, gene, gene activation, gene mutation, hematopoiesis, hemoglobin blood level, human, human tissue, immunohistochemistry, immunophenotyping, lymphoblast, lymphoblastoma/di [Diagnosis], lymphoblastoma/dt [Drug Therapy], lymphoblastoma/rt [Radiotherapy], lymphoid cell, mediastinum mass/di [Diagnosis], multiple cycle treatment, neutrophil count, nuclear magnetic resonance imaging, pancytopenia/di [Diagnosis], platelet count, positron emission tomography, pruritus, transbronchial biopsy, treatment failure, tumor volume, azacitidine/cb [Drug Combination], azacitidine/dt [Drug Therapy], azacitidine/pv [Special Situation for Pharmacovigilance], CD3 antigen/ec [Endogenous Compound], CD4 antigen/ec [Endogenous Compound], CD5 antigen/ec [Endogenous Compound], CD7 antigen/ec [Endogenous Compound], common acute lymphoblastic leukemia antigen, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], dexamethasone/dt [Drug Therapy], dexamethasone/po [Oral Drug Administration], dexamethasone/pv [Special Situation for Pharmacovigilance], DNA nucleotidylexotransferase/ec [Endogenous Compound], filgrastim/ae [Adverse Drug Reaction], filgrastim/cb [Drug Combination], filgrastim/dt [Drug Therapy], filgrastim/pv [Special Situation for Pharmacovigilance], fludarabine/ae [Adverse Drug Reaction], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], fludarabine/pv [Special Situation for Pharmacovigilance], fluorodeoxyglucose, hemoglobin/ec [Endogenous Compound], t6 antigen/ec [Endogenous Compound], tofacitinib/dt [Drug Therapy], tofacitinib/pv [Special Situation for Pharmacovigilance], tofacitinib/tm [Unexpected Outcome of Drug Treatment], venetoclax/cb [Drug Combination], venetoclax/dt [Drug Therapy], venetoclax/pv [Special Situation for Pharmacovigilance], DDX3X MLLT10 gene, JAK3 gene, T lymphoblastic leukaemia/di [Diagnosis], T lymphoblastic leukaemia/rt [Radiotherapy], fusion gene, aged, antigen expression, article, blood examination, bone marrow biopsy, cancer chemotherapy, cancer radiotherapy, cancer recurrence, cancer staging, case report, cell infiltration, clinical article, computer assisted tomography, contrast enhancement, drug response, drug withdrawal, dyspnea, fatigue, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29060
Click here for full text options
LibKey Link

المؤلفون: Fay K., Coyle L., Mackinlay N., Enjeti A., Stevenson W., Shortt J., Arthur C., Jeffrey A., Yip E., Katsioulas V., Nalpantidis A., Kerridge I., Greenwood M.

مصطلحات الفهرس: aged, article, cancer mortality, cancer survival, clinical outcome, cohort analysis, consolidation chemotherapy, faintness, febrile neutropenia, gastrointestinal hemorrhage, heart arrhythmia, human, induction chemotherapy, leukemia remission, low drug dose, lung edema, maintenance chemotherapy, major clinical study, male, mortality rate, multimodal chemotherapy, outpatient, overall survival, phase 2 clinical trial, pneumonia, priority journal, recurrence risk, retrospective study, thorax pain, treatment response, validation study, azacitidine/dt [Drug Therapy], azacitidine/pv [Special Situation for Pharmacovigilance], cytarabine/ct [Clinical Trial], cytarabine/ad [Drug Administration], cytarabine/do [Drug Dose], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/sc [Subcutaneous Drug Administration], tioguanine/ct [Clinical Trial], tioguanine/ad [Drug Administration], tioguanine/dt [Drug Therapy], tioguanine/po [Oral Drug Administration], tioguanine/pv [Special Situation for Pharmacovigilance], female, acute kidney failure, acute myeloid leukemia/dt [Drug Therapy], acute myeloid leukemia/rt [Radiotherapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35402
Leukemia and Lymphoma
Click here for full text options
LibKey Link

المؤلفون: Taubenheim N., Shortt J., Opat S., Wong J., Wall M., Corboy G.P., Gregory G.P.

مصطلحات الفهرس: febrile neutropenia/si [Side Effect], female, flow cytometry, fluorescence in situ hybridization, gene, gene activation, gene mutation, hematopoiesis, hemoglobin blood level, human, human tissue, immunohistochemistry, immunophenotyping, lymphoblast, lymphoblastoma/di [Diagnosis], lymphoblastoma/dt [Drug Therapy], lymphoblastoma/rt [Radiotherapy], lymphoid cell, mediastinum mass/di [Diagnosis], multiple cycle treatment, neutrophil count, nuclear magnetic resonance imaging, pancytopenia/di [Diagnosis], platelet count, positron emission tomography, pruritus, transbronchial biopsy, treatment failure, tumor volume, azacitidine/cb [Drug Combination], azacitidine/dt [Drug Therapy], azacitidine/pv [Special Situation for Pharmacovigilance], CD3 antigen/ec [Endogenous Compound], CD4 antigen/ec [Endogenous Compound], CD5 antigen/ec [Endogenous Compound], CD7 antigen/ec [Endogenous Compound], common acute lymphoblastic leukemia antigen, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], dexamethasone/dt [Drug Therapy], dexamethasone/po [Oral Drug Administration], dexamethasone/pv [Special Situation for Pharmacovigilance], DNA nucleotidylexotransferase/ec [Endogenous Compound], filgrastim/ae [Adverse Drug Reaction], filgrastim/cb [Drug Combination], filgrastim/dt [Drug Therapy], filgrastim/pv [Special Situation for Pharmacovigilance], fludarabine/ae [Adverse Drug Reaction], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], fludarabine/pv [Special Situation for Pharmacovigilance], fluorodeoxyglucose, hemoglobin/ec [Endogenous Compound], t6 antigen/ec [Endogenous Compound], tofacitinib/dt [Drug Therapy], tofacitinib/pv [Special Situation for Pharmacovigilance], tofacitinib/tm [Unexpected Outcome of Drug Treatment], venetoclax/cb [Drug Combination], venetoclax/dt [Drug Therapy], venetoclax/pv [Special Situation for Pharmacovigilance], DDX3X MLLT10 gene, JAK3 gene, T lymphoblastic leukaemia/di [Diagnosis], T lymphoblastic leukaemia/rt [Radiotherapy], fusion gene, aged, antigen expression, article, blood examination, bone marrow biopsy, cancer chemotherapy, cancer radiotherapy, cancer recurrence, cancer staging, case report, cell infiltration, clinical article, computer assisted tomography, contrast enhancement, drug response, drug withdrawal, dyspnea, fatigue, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29060
Cold Spring Harbor Molecular Case Studies
LibKey Link

المؤلفون: Fay K., Coyle L., Mackinlay N., Enjeti A., Stevenson W., Shortt J., Arthur C., Jeffrey A., Yip E., Katsioulas V., Nalpantidis A., Kerridge I., Greenwood M.

مصطلحات الفهرس: aged, article, cancer mortality, cancer survival, clinical outcome, cohort analysis, consolidation chemotherapy, faintness, febrile neutropenia, gastrointestinal hemorrhage, heart arrhythmia, human, induction chemotherapy, leukemia remission, low drug dose, lung edema, maintenance chemotherapy, major clinical study, male, mortality rate, multimodal chemotherapy, outpatient, overall survival, phase 2 clinical trial, pneumonia, priority journal, recurrence risk, retrospective study, thorax pain, treatment response, validation study, azacitidine/dt [Drug Therapy], azacitidine/pv [Special Situation for Pharmacovigilance], cytarabine/ct [Clinical Trial], cytarabine/ad [Drug Administration], cytarabine/do [Drug Dose], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/sc [Subcutaneous Drug Administration], tioguanine/ct [Clinical Trial], tioguanine/ad [Drug Administration], tioguanine/dt [Drug Therapy], tioguanine/po [Oral Drug Administration], tioguanine/pv [Special Situation for Pharmacovigilance], female, acute kidney failure, acute myeloid leukemia/dt [Drug Therapy], acute myeloid leukemia/rt [Radiotherapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35402
Leukemia and Lymphoma
LibKey Link

المؤلفون: Harrison S.J., Jefford M., Winship I., Millar J.L., Giles G.G., Seymour J.F., Milne R.L., Doo N.W., White V.M., Martin K., Bassett J.K., Prince H.M.

مصطلحات الفهرس: major clinical study, male, medical decision making, medical record review, medication compliance, middle aged, mortality risk, multiple cycle treatment, overall survival, population research, practice guideline, sample size, smoking, very elderly, bleomycin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/pv [Special Situation for Pharmacovigilance], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], dexamethasone/dt [Drug Therapy], dexamethasone/pv [Special Situation for Pharmacovigilance], doxorubicin/dt [Drug Therapy], doxorubicin/pv [Special Situation for Pharmacovigilance], etoposide/dt [Drug Therapy], etoposide/pv [Special Situation for Pharmacovigilance], ifosfamide/dt [Drug Therapy], ifosfamide/pv [Special Situation for Pharmacovigilance], methotrexate/dt [Drug Therapy], methotrexate/pv [Special Situation for Pharmacovigilance], prednisone/dt [Drug Therapy], prednisone/pv [Special Situation for Pharmacovigilance], rituximab/dt [Drug Therapy], rituximab/pv [Special Situation for Pharmacovigilance], vincristine/dt [Drug Therapy], vincristine/pv [Special Situation for Pharmacovigilance], bleomycin/pv [Special Situation for Pharmacovigilance], adult, aged, article, cancer radiotherapy, cancer registry, cancer survival, clinical feature, cohort analysis, comorbidity, controlled study, demography, diffuse large B cell lymphoma/di [Diagnosis], diffuse large B cell lymphoma/dt [Drug Therapy], diffuse large B cell lymphoma/ep [Epidemiology], diffuse large B cell lymphoma/rt [Radiotherapy], drug substitution, drug withdrawal, female, groups by age, health care access, health care delivery, hospitalization, human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36098
Cancers
Click here for full text options
LibKey Link

المؤلفون: Harrison S.J., Jefford M., Winship I., Millar J.L., Giles G.G., Seymour J.F., Milne R.L., Doo N.W., White V.M., Martin K., Bassett J.K., Prince H.M.

مصطلحات الفهرس: major clinical study, male, medical decision making, medical record review, medication compliance, middle aged, mortality risk, multiple cycle treatment, overall survival, population research, practice guideline, sample size, smoking, very elderly, bleomycin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/pv [Special Situation for Pharmacovigilance], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], dexamethasone/dt [Drug Therapy], dexamethasone/pv [Special Situation for Pharmacovigilance], doxorubicin/dt [Drug Therapy], doxorubicin/pv [Special Situation for Pharmacovigilance], etoposide/dt [Drug Therapy], etoposide/pv [Special Situation for Pharmacovigilance], ifosfamide/dt [Drug Therapy], ifosfamide/pv [Special Situation for Pharmacovigilance], methotrexate/dt [Drug Therapy], methotrexate/pv [Special Situation for Pharmacovigilance], prednisone/dt [Drug Therapy], prednisone/pv [Special Situation for Pharmacovigilance], rituximab/dt [Drug Therapy], rituximab/pv [Special Situation for Pharmacovigilance], vincristine/dt [Drug Therapy], vincristine/pv [Special Situation for Pharmacovigilance], bleomycin/pv [Special Situation for Pharmacovigilance], adult, aged, article, cancer radiotherapy, cancer registry, cancer survival, clinical feature, cohort analysis, comorbidity, controlled study, demography, diffuse large B cell lymphoma/di [Diagnosis], diffuse large B cell lymphoma/dt [Drug Therapy], diffuse large B cell lymphoma/ep [Epidemiology], diffuse large B cell lymphoma/rt [Radiotherapy], drug substitution, drug withdrawal, female, groups by age, health care access, health care delivery, hospitalization, human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36098
Cancers
LibKey Link